Collaboration Key To Chinese Innovation And Global Ambitions – China Healthcare Investment Conference
This article was originally published in The Pink Sheet Daily
BGI CEO Jun Wang and Simcere Founder Jisheng Ren share views on collaboration and talent retention in China.
You may also be interested in...
After announcing the intent to form a partnership a year ago, Merck & Co. announced Sept. 13, a collaboration with BGI (formerly the Beijing Genomics Institute) for discovery and development of biomarkers and genomic technologies
Throughout 2020, China’s drive to introduce more and newer drugs to the market did not slow but was rather accelerated by the COVID-19 pandemic. But can people afford them?
From bringing innovative new drugs to global markets, to record-setting fundraisings and initial public offerings, five trends are emerging in China's health sector that are worth closely watching in 2021.